Literature DB >> 33167757

Comprehensive Treatment Strategy for Internal Carotid Artery Blowout Syndrome Caused by Nasopharyngeal Carcinoma.

Zhouyang Zhao1, Lijin Huang1, Jinhua Chen1, Weijia Huang1, Xiaobin Zhang1, Yue Ma1, Hongshen Zhu1, Zhang Liu1.   

Abstract

OBJECTIVE: To evaluate a treatment strategy for internal carotid artery blowout syndrome caused by nasopharyngeal carcinoma. STUDY
DESIGN: A retrospective analysis of a case series was performed.
SETTING: Carotid blowout syndrome is a catastrophic complication caused by malignant tumor of the skull base.
METHODS: A retrospective analysis based on 69 patients with internal carotid artery blowout syndrome admitted to our center between April 2018 and January 2020 was performed. The patients were divided into 2 groups: an EBBA (internal carotid artery embolization + bypass based on American Society of Intervention and Therapeutic Neuroradiology/Society of Interventional Radiology [ASITN/SIR]) group and an embolization/stent group. The follow-up time was 6 to 9 months.
RESULTS: In the EBBA group, 41 patients (41/49, 83.7%) survived. Forty patients had a satisfactory quality of life after 3 months. No death occurred within 3 months. Nonoperative death occurred in 8 cases (8/49, 16.3%). The rate of mortality and disability was 18.4% (9/49). In the embolization/stent group, 16 patients (16/20, 80%) survived. Nonoperative death occurred in 4 cases (4/20, 20%), 3 of which occurred within 1 to 3 months. Four cases reported Modified Rankin Scale ≥2 after 3 months. The rate of mortality and disability was 40% (8/20).
CONCLUSION: A comprehensive revascularization strategy for internal carotid artery (ICA) embolization and intracranial and extracranial bypass grafting based on ASITN/SIR score for ICA blowout syndrome patients not only can prolong the patient survival but also greatly improve the survival probability and quality of life as well as reduce their rate of mortality or disability.

Entities:  

Keywords:  bypass; carotid blowout syndrome; embolization; head and neck cancer; oral and nasal massive hemorrhage

Year:  2020        PMID: 33167757     DOI: 10.1177/0194599820963129

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  2 in total

1.  Long-lasting olfactory dysfunction in COVID-19 patients.

Authors:  Bernhard Prem; David T Liu; Gerold Besser; Gunjan Sharma; Laura E Dultinger; Sissy V Hofer; Martina M Matiasczyk; Bertold Renner; Christian A Mueller
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-11-10       Impact factor: 2.503

2.  Acquired unilateral alopecia after arterial infusion chemotherapy in a recurrent nasopharyngeal carcinoma.

Authors:  Bao-Feng Duan; Hua-Ying Chen; Xue-Mei Zheng; Qing He
Journal:  Cancer Rep (Hoboken)       Date:  2022-07-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.